The global ischemia reperfusion injury market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing incidence of cardiovascular diseases and rising demand for minimally invasive surgeries. The global ischemia reperfusion injury market has been segmented on the basis of type, application, and region. On the basis of type, it has been classified into phase 1, phase 2, preclinical and ischemia reperfusion injury. On the basis of application it has been classified into heart injury, kidney injury and intestine injury. On the basis of region it has been classified into North America (US, Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- Increasing incidence of cardiovascular diseases and increasing number of surgeries are driving the growth of the global Ischemia Reperfusion Injury market.
- Increasing awareness about the side effects associated with Ischemia Reperfusion Injury is also driving the growth of this market globally.
- The high cost associated with treatment for Ischemia Reperfusion Injury is restraining this market's growth.
- Increasing research and development activities in this field are expected to fuel the growth of this market.
Industry Growth Insights published a new data on “Ischemia Reperfusion Injury Market”. The research report is titled “Ischemia Reperfusion Injury Market research by Types (Phase 1, Phase 2, Preclinical, Ischemia Reperfusion Injur), By Applications (Heart Injury, Kidney Injury, Intestine Injury, Other Injury), By Players/Companies Angion Biomedica, Catalyst Biosciences, Ischemix Inc, Opsona Therapeutics, Pharming, TheraSource, Bolder Biotechnology, Corline Biomedical, Mifcortx, Balmes Transplantation, NovelMed Therapeutics, Hope Pharmaceuticals, Omeros Corp, Prothix, SBI Pharmaceuticals, Ischemia Reperfusion Injur”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ischemia Reperfusion Injury Market Research Report
By Type
Phase 1, Phase 2, Preclinical, Ischemia Reperfusion Injur
By Application
Heart Injury, Kidney Injury, Intestine Injury, Other Injury
By Companies
Angion Biomedica, Catalyst Biosciences, Ischemix Inc, Opsona Therapeutics, Pharming, TheraSource, Bolder Biotechnology, Corline Biomedical, Mifcortx, Balmes Transplantation, NovelMed Therapeutics, Hope Pharmaceuticals, Omeros Corp, Prothix, SBI Pharmaceuticals, Ischemia Reperfusion Injur
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Ischemia Reperfusion Injury Market Report Segments:
The global Ischemia Reperfusion Injury market is segmented on the basis of:
Types
Phase 1, Phase 2, Preclinical, Ischemia Reperfusion Injur
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Heart Injury, Kidney Injury, Intestine Injury, Other Injury
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Angion Biomedica
- Catalyst Biosciences
- Ischemix Inc
- Opsona Therapeutics
- Pharming
- TheraSource
- Bolder Biotechnology
- Corline Biomedical
- Mifcortx
- Balmes Transplantation
- NovelMed Therapeutics
- Hope Pharmaceuticals
- Omeros Corp
- Prothix
- SBI Pharmaceuticals
- Ischemia Reperfusion Injur
Highlights of The Ischemia Reperfusion Injury Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Phase 1
- Phase 2
- Preclinical
- Ischemia Reperfusion Injur
- By Application:
- Heart Injury
- Kidney Injury
- Intestine Injury
- Other Injury
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ischemia Reperfusion Injury Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ischemia reperfusion injury (IRI) is a condition that can occur after an interruption of blood flow to the body. This can be caused by a number of factors, including heart attack, stroke, or surgery. IRI can cause damage to tissues and organs in the body and lead to serious health problems.
Some of the key players operating in the ischemia reperfusion injury market are Angion Biomedica, Catalyst Biosciences, Ischemix Inc, Opsona Therapeutics, Pharming, TheraSource, Bolder Biotechnology, Corline Biomedical, Mifcortx, Balmes Transplantation, NovelMed Therapeutics, Hope Pharmaceuticals, Omeros Corp, Prothix, SBI Pharmaceuticals, Ischemia Reperfusion Injur.
The ischemia reperfusion injury market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ischemia Reperfusion Injury Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ischemia Reperfusion Injury Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ischemia Reperfusion Injury Market - Supply Chain
4.5. Global Ischemia Reperfusion Injury Market Forecast
4.5.1. Ischemia Reperfusion Injury Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ischemia Reperfusion Injury Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ischemia Reperfusion Injury Market Absolute $ Opportunity
5. Global Ischemia Reperfusion Injury Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ischemia Reperfusion Injury Market Size and Volume Forecast by Type
5.3.1. Phase 1
5.3.2. Phase 2
5.3.3. Preclinical
5.3.4. Ischemia Reperfusion Injur
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ischemia Reperfusion Injury Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ischemia Reperfusion Injury Market Size and Volume Forecast by Application
6.3.1. Heart Injury
6.3.2. Kidney Injury
6.3.3. Intestine Injury
6.3.4. Other Injury
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ischemia Reperfusion Injury Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ischemia Reperfusion Injury Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ischemia Reperfusion Injury Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ischemia Reperfusion Injury Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ischemia Reperfusion Injury Demand Share Forecast, 2019-2026
9. North America Ischemia Reperfusion Injury Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ischemia Reperfusion Injury Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ischemia Reperfusion Injury Market Size and Volume Forecast by Application
9.4.1. Heart Injury
9.4.2. Kidney Injury
9.4.3. Intestine Injury
9.4.4. Other Injury
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ischemia Reperfusion Injury Market Size and Volume Forecast by Type
9.7.1. Phase 1
9.7.2. Phase 2
9.7.3. Preclinical
9.7.4. Ischemia Reperfusion Injur
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ischemia Reperfusion Injury Demand Share Forecast, 2019-2026
10. Latin America Ischemia Reperfusion Injury Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ischemia Reperfusion Injury Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ischemia Reperfusion Injury Market Size and Volume Forecast by Application
10.4.1. Heart Injury
10.4.2. Kidney Injury
10.4.3. Intestine Injury
10.4.4. Other Injury
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ischemia Reperfusion Injury Market Size and Volume Forecast by Type
10.7.1. Phase 1
10.7.2. Phase 2
10.7.3. Preclinical
10.7.4. Ischemia Reperfusion Injur
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ischemia Reperfusion Injury Demand Share Forecast, 2019-2026
11. Europe Ischemia Reperfusion Injury Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ischemia Reperfusion Injury Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ischemia Reperfusion Injury Market Size and Volume Forecast by Application
11.4.1. Heart Injury
11.4.2. Kidney Injury
11.4.3. Intestine Injury
11.4.4. Other Injury
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ischemia Reperfusion Injury Market Size and Volume Forecast by Type
11.7.1. Phase 1
11.7.2. Phase 2
11.7.3. Preclinical
11.7.4. Ischemia Reperfusion Injur
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ischemia Reperfusion Injury Demand Share, 2019-2026
12. Asia Pacific Ischemia Reperfusion Injury Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ischemia Reperfusion Injury Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ischemia Reperfusion Injury Market Size and Volume Forecast by Application
12.4.1. Heart Injury
12.4.2. Kidney Injury
12.4.3. Intestine Injury
12.4.4. Other Injury
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ischemia Reperfusion Injury Market Size and Volume Forecast by Type
12.7.1. Phase 1
12.7.2. Phase 2
12.7.3. Preclinical
12.7.4. Ischemia Reperfusion Injur
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ischemia Reperfusion Injury Demand Share, 2019-2026
13. Middle East & Africa Ischemia Reperfusion Injury Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ischemia Reperfusion Injury Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ischemia Reperfusion Injury Market Size and Volume Forecast by Application
13.4.1. Heart Injury
13.4.2. Kidney Injury
13.4.3. Intestine Injury
13.4.4. Other Injury
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ischemia Reperfusion Injury Market Size and Volume Forecast by Type
13.7.1. Phase 1
13.7.2. Phase 2
13.7.3. Preclinical
13.7.4. Ischemia Reperfusion Injur
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ischemia Reperfusion Injury Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ischemia Reperfusion Injury Market: Market Share Analysis
14.2. Ischemia Reperfusion Injury Distributors and Customers
14.3. Ischemia Reperfusion Injury Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Angion Biomedica
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Catalyst Biosciences
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Ischemix Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Opsona Therapeutics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pharming
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. TheraSource
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bolder Biotechnology
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Corline Biomedical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mifcortx
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Balmes Transplantation
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. NovelMed Therapeutics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Hope Pharmaceuticals
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Omeros Corp
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Prothix
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. SBI Pharmaceuticals
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Ischemia Reperfusion Injur
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook